{
    "clinical_study": {
        "@rank": "63852", 
        "arm_group": [
            {
                "arm_group_label": "Experimental: Femtosecond laser cataract surgery", 
                "arm_group_type": "Experimental", 
                "description": "\"Laser group\": a pre-fragmentation of the ocular lens will be performed by VICTUS femtosecond laser lens fragmentation procedure."
            }, 
            {
                "arm_group_label": "Manual cataract surgery", 
                "arm_group_type": "Active Comparator", 
                "description": "\"Manual\": manual group acts as a control group where the lens fragmentation are performed manually without femtosecond laser assisted lens fragmentation"
            }
        ], 
        "brief_summary": {
            "textblock": "This clinical study is a prospective, post-market-clinical-follow-up study to investigate\n      the long-term (3 months) safety of femtosecond laser assisted cataract surgery as a study\n      follow-up extension to the Study #1304 titled as \"A Multi-centre, Multi-surgeon, Randomized,\n      Controlled, Prospective, Post-Market-Clinical-Follow-Up Study to Investigate the Impact of\n      Cataract Grade on the Efficacy and Safety of Femtosecond-laser Assisted Lens Fragmentation\n      Procedure\"."
        }, 
        "brief_title": "Long-term (3 Months) Safety of Femtosecond-laser Assisted Cataract Surgery", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Cataract", 
        "condition_browse": {
            "mesh_term": "Cataract"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Only the patients who were successfully enrolled in Study #1304 are eligible for this\n        follow-up extension study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "132", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02023437", 
            "org_study_id": "1304_3M"
        }, 
        "intervention": [
            {
                "arm_group_label": "Experimental: Femtosecond laser cataract surgery", 
                "description": "The VICTUS lens fragmentation procedure is part of the femtosecond laser assisted cataract procedure, which generates precise cuts inside the cataractous lens, leading to a softening and fragmentation of the lens.", 
                "intervention_name": "Femtosecond laser cataract surgery", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Manual cataract surgery", 
                "description": "\"Manual\": manual group acts as a control group where the lens fragmentation are per-formed manually without femtosecond laser assisted lens fragmentation", 
                "intervention_name": "Manual cataract surgery", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 22, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Zlin", 
                        "country": "Czech Republic", 
                        "zip": "76001"
                    }, 
                    "name": "Gemini Eye Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hyderabad", 
                        "country": "India", 
                        "zip": "500082"
                    }, 
                    "name": "MaxiVision Laser Centre Private Limited"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Czech Republic", 
                "India"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Post-Market-Clinical-Follow-Up Study to Investigate the Long-term (3 Months) Safety of Femtosecond-laser Assisted Cataract Surgery", 
        "overall_official": [
            {
                "affiliation": "Gemini clinic, Zlin, Czech Republic 76001", 
                "last_name": "Pavel Stodulka, Dr. Med.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "MaxiVision Laser Centre Private Limited, Hyderabad, India", 
                "last_name": "Kasu P Reddy, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "MaxiVision Laser Centre Private Limited, Hyderabad, India", 
                "last_name": "N Sreelakshmi, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Slade & Baker Vision Center", 
                "last_name": "Steve Slade, M.D.", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Czech Republic: Ethics Committee", 
                "India: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Less or equal adverse events (e.g. retinal detachment, intraocular lens (IOL) malposition, etc.) in \"Laser group\" (pooled from all cataract grades) compared with \"Manual group\" (pooled from all cataract grades); p<0.05 will be considered statistically significant. The primary study end point is only based on adverse events and severe adverse events which are related to the treatment procedures.", 
            "measure": "Adverse Events", 
            "safety_issue": "Yes", 
            "time_frame": "3 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02023437"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Technolas Perfect Vision GmbH", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Technolas Perfect Vision GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}